| Income Statement |
| Total Revenue | 10.72M |
|
| Revenues (USD) | 10.72M |
| Cost of Revenue | 2.27M |
| Gross Profit | 8.45M |
| Operating Expenses | 9.05M |
| Research and Development Expense | 849.00K |
| Selling, General and Administrative Expense | 8.20M |
| Operating Income | -598.00K |
| Interest Expense | 267.00K |
| Net Income | -865.00K |
| Net Income Common Stock | -865.00K |
| Net Income Common Stock (USD) | -865.00K |
| Consolidated Income | -865.00K |
| Earnings per Basic Share | -0.07 |
| Earnings per Basic Share (USD) | -0.07 |
| Earnings per Diluted Share | -0.07 |
| Earning Before Interest & Taxes (EBIT) | -598.00K |
| Earning Before Interest & Taxes (USD) | -598.00K |
| Weighted Average Shares | 12.49M |
| Weighted Average Shares Diluted | 12.49M |
| Balance Sheet |
| Cash and Equivalents | 8.72M |
| Cash and Equivalents (USD) | 8.72M |
| Trade and Non-Trade Receivables | 6.72M |
| Current Assets | 16.31M |
| Property, Plant & Equipment Net | 420.00K |
| Total Assets | 34.88M |
| Debt Current | 906.00K |
| Total Debt | 16.74M |
| Current Liabilities | 15.33M |
| Debt Non-Current | 15.83M |
| Total Liabilities | 31.66M |
| Accumulated Retained Earnings (Deficit) | -106.85M |
| Shareholders Equity | 3.22M |
| Shareholders Equity (USD) | 3.22M |
| Assets Non-Current | 18.58M |
| Total Debt (USD) | 16.74M |
| Deferred Revenue | 9.39M |
| Goodwill and Intangible Assets | 18.12M |
| Liabilities Non-Current | 16.33M |
| Trade and Non-Trade Payables | 4.97M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 977.00K |
| Net Cash Flow from Financing | -445.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 154.00K |
| Capital Expenditure | -389.00K |
| Issuance (Purchase) of Equity Shares | -232.00K |
| Issuance (Repayment) of Debt Securities | -213.00K |
| Net Cash Flow from Investing | -418.00K |
| Net Cash Flow from Operations | 1.02M |
| Share Based Compensation | 1.14M |